期刊文献+

Carnitine deficiency in intensive care unit patients undergoing continuous renal replacement therapy—An underrecognized issue with potential for severe complications

原文传递
导出
摘要 Introduction Carnitine plays a crucial role in energy metabolism by transporting long-chain fatty acids into mitochondria for𝛽-oxidation and removing waste metabolites.[1]Approximately 98%of the body’s total carnitine is stored in skeletal muscle,with blood serving as the transport medium.[2]Carnitine is synthesized in the liver and kidneys from lysine and methionine,but endogenous production is limited.The body preserves carnitine levels through renal reabsorption and stores in organs such as skeletal muscles,the liver,kidneys,and heart.[3]However,carnitine deficiency is prevalent in approximately 95%of hemodialysis patients due to extracorporeal loss during dialysis and impaired renal synthesis.[4]L-carnitine replacement therapy can mitigate complications,including cardiac issues,anemia,and muscle weakness.
机构地区 ICU
出处 《Journal of Intensive Medicine》 2025年第3期249-251,共3页 重症医学(英文)

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部